Safety of leukoreduced, cytomegalovirus (CMV)‐untested components in CMV‐negative allogeneic human progenitor cell transplant recipientsTammon Nash, Laura Cooling, Sandra Hoffmann et al.|Transfusion|2012Cited by 35